{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,7,23]],"date-time":"2025-07-23T12:47:11Z","timestamp":1753274831917,"version":"3.37.3"},"reference-count":50,"publisher":"Springer Science and Business Media LLC","issue":"9","license":[{"start":{"date-parts":[[2022,6,21]],"date-time":"2022-06-21T00:00:00Z","timestamp":1655769600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.springer.com\/tdm"},{"start":{"date-parts":[[2022,6,21]],"date-time":"2022-06-21T00:00:00Z","timestamp":1655769600000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/www.springer.com\/tdm"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Mol Biol Rep"],"published-print":{"date-parts":[[2022,9]]},"DOI":"10.1007\/s11033-022-07665-x","type":"journal-article","created":{"date-parts":[[2022,6,21]],"date-time":"2022-06-21T19:39:42Z","timestamp":1655840382000},"page":"8461-8472","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":4,"title":["The role of the PTEN\/mTOR axis in clinical response of rectal cancer patients"],"prefix":"10.1007","volume":"49","author":[{"ORCID":"https:\/\/orcid.org\/0000-0003-1581-2207","authenticated-orcid":false,"given":"Oya","family":"Orun","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Sevgi","family":"\u00d6zden","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Olca","family":"K\u0131l\u0131n\u00e7","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"P\u0131nar","family":"Mega Tiber","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Pelin","family":"Yonar","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Zerrin","family":"\u00d6zgen","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Hazan","family":"\u00d6zyurt","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2022,6,21]]},"reference":[{"key":"7665_CR1","doi-asserted-by":"publisher","first-page":"1622","DOI":"10.3390\/cancers3021622","volume":"3","author":"M Kulendran","year":"2011","unstructured":"Kulendran M, Stebbing JF, Marks CG, Rockall TA (2011) Predictive and prognostic factors in colorectal cancer: a personalized approach. Cancers 3:1622\u20131638. https:\/\/doi.org\/10.3390\/cancers3021622","journal-title":"Cancers"},{"key":"7665_CR2","doi-asserted-by":"publisher","first-page":"573","DOI":"10.3390\/ijms18030573","volume":"18","author":"D Dayde","year":"2017","unstructured":"Dayde D, Tanaka I, Jain R, Tai MC, Taguchi A (2017) Predictive and prognostic molecular biomarkers for response to neoadjuvant chemoradiation in rectal cancer. Int J Mol Sci 18:573. https:\/\/doi.org\/10.3390\/ijms18030573","journal-title":"Int J Mol Sci"},{"key":"7665_CR3","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pone.0007287","volume":"4","author":"A Sartore-Bianchi","year":"2009","unstructured":"Sartore-Bianchi A, Di Nicolantonio F, Nichelatti M, Molinari F, De Dosso S, Saletti P et al (2009) Multi-determinants analysis of molecular alterations for predicting clinical benefit to EGFR-targeted monoclonal antibodies in colorectal cancer. PLoS ONE 4:e7287. https:\/\/doi.org\/10.1371\/journal.pone.0007287","journal-title":"PLoS ONE"},{"key":"7665_CR4","doi-asserted-by":"publisher","first-page":"1828","DOI":"10.3892\/or.2015.3804","volume":"33","author":"Y Sun","year":"2015","unstructured":"Sun Y, Tian H, Wang L (2015) Effects of PTEN on the proliferation and apoptosis of colorectal cancer cells via the phosphoinositol-3-kinase\/Akt pathway. Oncol Rep 33:1828\u20131836. https:\/\/doi.org\/10.3892\/or.2015.3804","journal-title":"Oncol Rep"},{"key":"7665_CR5","doi-asserted-by":"publisher","first-page":"1098","DOI":"10.1126\/science.1106148","volume":"307","author":"DD Sarbassov","year":"2005","unstructured":"Sarbassov DD, Guertin DA, Ali SM, Sabatini DM (2005) Phosphorylation and regulation of Akt\/PKB by the Rictor-mTOR complex. Science 307:1098\u20131101. https:\/\/doi.org\/10.1126\/science.1106148","journal-title":"Science"},{"issue":"1","key":"7665_CR6","doi-asserted-by":"publisher","first-page":"59","DOI":"10.1186\/2045-3701-4-59","volume":"4","author":"CH Chan","year":"2014","unstructured":"Chan CH, Jo U, Kohrman A, Rezaeian AH, Chou PC, Logothetis C, Lin HK (2014) Posttranslational regulation of Akt in human cancer. Cell Biosci 4(1):59. https:\/\/doi.org\/10.1186\/2045-3701-4-59","journal-title":"Cell Biosci"},{"key":"7665_CR7","doi-asserted-by":"publisher","first-page":"381","DOI":"10.1016\/j.cell.2017.04.001","volume":"169","author":"BD Manning","year":"2017","unstructured":"Manning BD, Toker A (2017) AKT\/PKB signaling: navigating the network. Cell 169:381\u2013405. https:\/\/doi.org\/10.1016\/j.cell.2017.04.001","journal-title":"Cell"},{"key":"7665_CR8","doi-asserted-by":"publisher","first-page":"4905","DOI":"10.3748\/wjg.v17.i44.4905","volume":"17","author":"SA Ozden","year":"2011","unstructured":"Ozden SA, Ozyurt H, Ozgen Z, Kilinc O, Oncel M, Gul AE, Karadayi N, Serakinci N, Kan B, Orun O (2011) Prognostic role of sensitive-to-apoptosis gene expression in rectal cancer. World J Gastroenterol 17:4905\u20134910. https:\/\/doi.org\/10.3748\/wjg.v17.i44.4905","journal-title":"World J Gastroenterol"},{"key":"7665_CR9","doi-asserted-by":"publisher","first-page":"2161","DOI":"10.2147\/OTT.S71448","volume":"7","author":"P Mega Tiber","year":"2014","unstructured":"Mega Tiber P, Baloglu L, Ozden S, Ozgen Z, Ozyurt H, Eren M, Orun O (2014) The association of apoptotic protein expressions sensitive to apoptosis gene, p73 and p53 with the prognosis of cervical carcinoma. Onco Targets Ther 7:2161\u20132168. https:\/\/doi.org\/10.2147\/OTT.S71448","journal-title":"Onco Targets Ther"},{"key":"7665_CR10","doi-asserted-by":"publisher","first-page":"814","DOI":"10.1158\/1078-0432.CCR-09-1592","volume":"20116","author":"L Jia","year":"2010","unstructured":"Jia L, Yang J, Hao X, Zheng M, He H, Xiong X, Xu L, Sun Y (2010) Validation of SAG\/RBX2\/ROC2 E3 ubiquitin ligase as an anticancer and radiosensitizing target. Clin Cancer Res 20116:814\u2013824. https:\/\/doi.org\/10.1158\/1078-0432.CCR-09-1592","journal-title":"Clin Cancer Res"},{"key":"7665_CR11","doi-asserted-by":"publisher","first-page":"700","DOI":"10.1177\/1947601910382776","volume":"1","author":"D Wei","year":"2010","unstructured":"Wei D, Sun Y (2010) Small ring finger proteins RBX1 and RBX2 of SCF E3 ubiquitin ligases: the role in cancer and as cancer targets. Genes Cancer 1:700\u2013707. https:\/\/doi.org\/10.1177\/1947601910382776","journal-title":"Genes Cancer"},{"key":"7665_CR12","doi-asserted-by":"publisher","first-page":"304","DOI":"10.1016\/j.molcel.2011.08.029","volume":"44","author":"Y Zhao","year":"2011","unstructured":"Zhao Y, Xiong X, Sun Y (2011) DEPTOR, an mTOR inhibitor, is a physiological substrate of SCF (\u03b2TrCP) E3 ubiquitin ligase and regulates survival and autophagy. Mol Cell 44:304\u2013316. https:\/\/doi.org\/10.1016\/j.molcel.2011.08.029","journal-title":"Mol Cell"},{"key":"7665_CR13","doi-asserted-by":"publisher","first-page":"290","DOI":"10.1016\/j.molcel.2011.08.030","volume":"44","author":"D Gao","year":"2011","unstructured":"Gao D, Inuzuka H, Tan MK, Fukushima H, Locasale JW, Liu P et al (2011) mTOR drives its own activation via SCF(\u03b2TrCP)-dependent degradation of the mTOR inhibitor DEPTOR. Mol Cell 44:290\u2013303. https:\/\/doi.org\/10.1016\/j.molcel.2011.08.030","journal-title":"Mol Cell"},{"key":"7665_CR14","doi-asserted-by":"publisher","first-page":"647","DOI":"10.1002\/ijc.30089","volume":"139","author":"IM L\u00f8es","year":"2016","unstructured":"L\u00f8es IM, Immervoll H, Sorbye H, Angelsen JH, Horn A, Knappskog S, L\u00f8nning PE (2016) Impact of KRAS, BRAF, PIK3CA, TP53 status and intraindividual mutation heterogeneity on outcome after liver resection for colorectal cancer metastases. Int J Cancer 139:647\u2013656. https:\/\/doi.org\/10.1002\/ijc.30089","journal-title":"Int J Cancer"},{"key":"7665_CR15","doi-asserted-by":"publisher","first-page":"280","DOI":"10.1016\/j.suronc.2018.05.012","volume":"27","author":"DI Tsilimigras","year":"2018","unstructured":"Tsilimigras DI, Ntanasis-Stathopoulos I, Bagante F, Moris D, Cloyd J, Spartalis E, Pawlik TM (2018) Clinical significance and prognostic relevance of KRAS, BRAF, PI3K and TP53 genetic mutation analysis for resectable and unresectable colorectal liver metastases: a systematic review of the current evidence. Surg Oncol 27:280\u2013288. https:\/\/doi.org\/10.1016\/j.suronc.2018.05.012","journal-title":"Surg Oncol"},{"key":"7665_CR16","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pone.0045388","volume":"7","author":"MB Chen","year":"2012","unstructured":"Chen MB, Wu XY, Yu R, Li C, Wang LQ, Shen W, Lu PH (2012) P53 status as a predictive biomarker for patients receiving neoadjuvant radiation-based treatment: a meta-analysis in rectal cancer. PLoS ONE 7:e45388. https:\/\/doi.org\/10.1371\/journal.pone.0045388","journal-title":"PLoS ONE"},{"key":"7665_CR17","doi-asserted-by":"publisher","first-page":"82","DOI":"10.3349\/ymj.2015.56.1.82","volume":"56","author":"JW Huh","year":"2015","unstructured":"Huh JW, Lee WY, Kim SH, Park YA, Cho YB, Yun SH et al (2015) Immunohistochemical detection of p53 expression in patients with preoperative chemoradiation for rectal cancer: association with prognosis. Yonsei Med J 56:82\u201388. https:\/\/doi.org\/10.3349\/ymj.2015.56.1.82","journal-title":"Yonsei Med J"},{"key":"7665_CR18","doi-asserted-by":"publisher","first-page":"98","DOI":"10.1007\/s12032-015-0519-9","volume":"32","author":"Y Lu","year":"2015","unstructured":"Lu Y, Gao J, Lu Y (2015) Down-expression pattern of Ku70 and p53 coexisted in colorectal cancer. Med Oncol 32:98. https:\/\/doi.org\/10.1007\/s12032-015-0519-9","journal-title":"Med Oncol"},{"key":"7665_CR19","doi-asserted-by":"publisher","first-page":"283","DOI":"10.1038\/nrm3330","volume":"13","author":"MS Song","year":"2012","unstructured":"Song MS, Salmena L, Pandolfi PP (2012) The functions and regulation of the PTEN tumour suppressor. Nat Rev Mol Cell Biol 13:283\u2013296. https:\/\/doi.org\/10.1038\/nrm3330","journal-title":"Nat Rev Mol Cell Biol"},{"key":"7665_CR20","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1042\/BJ20040825","volume":"382","author":"NR Leslie","year":"2004","unstructured":"Leslie NR, Downes CP (2004) PTEN function: how normal cells control it and tumour cells lose it. Biochem J 382:1\u201311. https:\/\/doi.org\/10.1042\/BJ20040825","journal-title":"Biochem J"},{"key":"7665_CR21","doi-asserted-by":"publisher","first-page":"127","DOI":"10.1146\/annurev.pathol.4.110807.092311","volume":"4","author":"N Chalhoub","year":"2009","unstructured":"Chalhoub N, Baker SJ (2009) PTEN and the PI3-kinase pathway in cancer. Annu Rev Pathol 4:127\u2013150. https:\/\/doi.org\/10.1146\/annurev.pathol.4.110807.092311","journal-title":"Annu Rev Pathol"},{"key":"7665_CR22","doi-asserted-by":"publisher","first-page":"184","DOI":"10.1016\/j.canlet.2005.11.042","volume":"241","author":"LM Chow","year":"2006","unstructured":"Chow LM, Baker SJ (2006) PTEN function in normal and neoplastic growth. Cancer Lett 241:184\u2013196. https:\/\/doi.org\/10.1016\/j.canlet.2005.11.042","journal-title":"Cancer Lett"},{"key":"7665_CR23","doi-asserted-by":"publisher","first-page":"56","DOI":"10.1186\/1471-230X-8-56","volume":"8","author":"H Sawai","year":"2008","unstructured":"Sawai H, Yasuda A, Ochi N, Ma J, Matsuo Y, Wakasugi T et al (2008) Loss of PTEN expression is associated with colorectal cancer liver metastasis and poor patient survival. BMC Gastroenterol 8:56. https:\/\/doi.org\/10.1186\/1471-230X-8-56","journal-title":"BMC Gastroenterol"},{"key":"7665_CR24","doi-asserted-by":"publisher","first-page":"2153","DOI":"10.1038\/bjc.2013.212","volume":"108","author":"V Ekl\u00f6f","year":"2013","unstructured":"Ekl\u00f6f V, Wikberg ML, Edin S, Dahlin AM, Jonsson BA, \u00d6berg \u00c5, Ruteg\u00e5rd J, Palmqvist R (2013) The prognostic role of KRAS, BRAF, PIK3CA and PTEN in colorectal cancer. Br J Cancer 108:2153\u20132163. https:\/\/doi.org\/10.1038\/bjc.2013.212","journal-title":"Br J Cancer"},{"key":"7665_CR25","doi-asserted-by":"publisher","first-page":"317","DOI":"10.1016\/S1097-2765(01)00323-9","volume":"8","author":"V Stambolic","year":"2001","unstructured":"Stambolic V, MacPherson D, Sas D, Lin Y, Snow B, Jang Y, Benchimol S, Mak TW (2001) Regulation of PTEN transcription by p53. Mol Cell 8:317\u2013325. https:\/\/doi.org\/10.1016\/S1097-2765(01)00323-9","journal-title":"Mol Cell"},{"key":"7665_CR26","doi-asserted-by":"publisher","first-page":"218","DOI":"10.1038\/sj.cdd.4401946","volume":"14","author":"K Hettinger","year":"2007","unstructured":"Hettinger K, Vikhanskaya F, Poh MK, Lee MK, de Belle I, Zhang JT, Reddy SA, Sabapathy K (2007) c-Jun promotes cellular survival by suppression of PTEN. Cell Death Differ 14:218\u2013229. https:\/\/doi.org\/10.1038\/sj.cdd.4401946","journal-title":"Cell Death Differ"},{"key":"7665_CR27","doi-asserted-by":"publisher","first-page":"166","DOI":"10.3389\/fonc.2015.00166","volume":"5","author":"M Berm\u00fadez Brito","year":"2015","unstructured":"Berm\u00fadez Brito M, Goulielmaki E, Papakonstanti EA (2015) Focus on PTEN regulation. Front Oncol 5:166. https:\/\/doi.org\/10.3389\/fonc.2015.00166","journal-title":"Front Oncol"},{"key":"7665_CR28","doi-asserted-by":"publisher","first-page":"1524","DOI":"10.1016\/j.humpath.2012.12.006","volume":"4","author":"BA Bohn","year":"2013","unstructured":"Bohn BA, Mina S, Krohn A, Simon R, Kluth M, Harasimowicz S et al (2013) Altered PTEN function caused by deletion or gene disruption is associated with poor prognosis in rectal but not in colon cancer. Hum Pathol 4:1524\u20131533. https:\/\/doi.org\/10.1016\/j.humpath.2012.12.006","journal-title":"Hum Pathol"},{"key":"7665_CR29","doi-asserted-by":"publisher","first-page":"574","DOI":"10.1016\/j.neo.2018.03.002","volume":"20","author":"X Wang","year":"2018","unstructured":"Wang X, Cao X, Sun R, Tang C, Tzankov A, Zhang J et al (2018) Clinical significance of PTEN deletion, mutation, and loss of PTEN expression in de novo diffuse large B-cell lymphoma. Neoplasia 20:574\u2013593. https:\/\/doi.org\/10.1016\/j.neo.2018.03.002","journal-title":"Neoplasia"},{"key":"7665_CR30","doi-asserted-by":"publisher","first-page":"32043","DOI":"10.18632\/oncotarget.16761","volume":"8","author":"S Li","year":"2017","unstructured":"Li S, Shen Y, Wang M, Yang J, Lv M, Li P, Chen Z, Yang J (2017) Loss of PTEN expression in breast cancer: association with clinicopathological characteristics and prognosis. Oncotarget 8:32043\u201332054. https:\/\/doi.org\/10.18632\/oncotarget.16761","journal-title":"Oncotarget"},{"key":"7665_CR31","doi-asserted-by":"publisher","first-page":"1589","DOI":"10.2147\/OTT.S102421","volume":"9","author":"J Zhao","year":"2016","unstructured":"Zhao J, Chen F, Zhou Q, Pan W, Wang X, Xu J, Ni L, Yang H (2016) Aberrant expression of microRNA-99a and its target gene mTOR associated with malignant progression and poor prognosis in patients with osteosarcoma. Onco Targets Ther 9:1589\u20131597. https:\/\/doi.org\/10.2147\/OTT.S102421","journal-title":"Onco Targets Ther"},{"key":"7665_CR32","doi-asserted-by":"publisher","first-page":"221","DOI":"10.1007\/s10238-017-0478-x","volume":"18","author":"A Khanna","year":"2018","unstructured":"Khanna A, Bhushan B, Chauhan PS, Saxena S, Gupta DK, Siraj F (2018) High mTOR expression independently prognosticates poor clinical outcome to induction chemotherapy in acute lymphoblastic leukemia. Clin Exp Med 18:221\u2013227. https:\/\/doi.org\/10.1007\/s10238-017-0478-x","journal-title":"Clin Exp Med"},{"key":"7665_CR33","doi-asserted-by":"publisher","first-page":"919","DOI":"10.1007\/s10620-014-3417-7","volume":"60","author":"M Kaibori","year":"2015","unstructured":"Kaibori M, Shikata N, Sakaguchi T, Ishizaki M, Matsui K, Iida H et al (2015) Influence of rictor and raptor expression of mTOR signaling on long-term outcomes of patients with hepatocellular carcinoma. Dig Dis Sci 60:919\u2013928. https:\/\/doi.org\/10.1007\/s10620-014-3417-7","journal-title":"Dig Dis Sci"},{"key":"7665_CR34","doi-asserted-by":"publisher","first-page":"R96","DOI":"10.1186\/bcr3557","volume":"15","author":"E Karlsson","year":"2013","unstructured":"Karlsson E, P\u00e9rez-Tenorio G, Amin R, Bostner J, Skoog L, Fornander T, Sgroi DC, Nordenskj\u00f6ld B, Hallbeck AL, St\u00e5l O (2013) The mTOR effectors 4EBP1 and S6K2 are frequently coexpressed, and associated with a poor prognosis and endocrine resistance in breast cancer: a retrospective study including patients from the randomised Stockholm tamoxifen trials. Breast Cancer Res 15:R96. https:\/\/doi.org\/10.1186\/bcr3557","journal-title":"Breast Cancer Res"},{"key":"7665_CR35","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pone.0119015","volume":"10","author":"K Kakumoto","year":"2015","unstructured":"Kakumoto K, Ikeda J, Okada M, Morii E, Oneyama C (2015) mLST8 promotes mTOR-mediated tumor progression. PLoS ONE 10:e0119015. https:\/\/doi.org\/10.1371\/journal.pone.0119015","journal-title":"PLoS ONE"},{"key":"7665_CR36","doi-asserted-by":"publisher","first-page":"995","DOI":"10.1016\/s1097-2765(02)00706-2","volume":"10","author":"LW Ellisen","year":"2002","unstructured":"Ellisen LW, Ramsayer KD, Johannessen CM, Yang A, Beppu H, Minda K, Oliner JD, McKeon F, Haber DA (2002) REDD1, a developmentally regulated transcriptional target of p63 and p53, links p63 to regulation of reactive oxygen species. Mol Cell 10:995\u20131005. https:\/\/doi.org\/10.1016\/s1097-2765(02)00706-2","journal-title":"Mol Cell"},{"key":"7665_CR37","doi-asserted-by":"publisher","first-page":"2283","DOI":"10.1128\/MCB.22.7.2283-2293.2002","volume":"22","author":"T Shoshani","year":"2002","unstructured":"Shoshani T, Faerman A, Mett I, Zelin E, Tenne T, Gorodin S et al (2002) Identification of a novel hypoxia-inducible factor 1-responsive gene, RTP801, involved in apoptosis. Mol Cell Biol 22:2283\u20132293. https:\/\/doi.org\/10.1128\/MCB.22.7.2283-2293.2002","journal-title":"Mol Cell Biol"},{"key":"7665_CR38","doi-asserted-by":"publisher","first-page":"866","DOI":"10.1038\/embor.2009.93","volume":"10","author":"S Katiyar","year":"2009","unstructured":"Katiyar S, Liu E, Knutzen CA, Lang ES, Lombardo CR, Sankar S, Toth JI, Petroski MD, Ronai Z, Chiang GG (2009) REDD1, an inhibitor of mTOR signalling, is regulated by the CUL4A-DDB1 ubiquitin ligase. EMBO Rep 10:866\u2013872. https:\/\/doi.org\/10.1038\/embor.2009.93","journal-title":"EMBO Rep"},{"key":"7665_CR39","doi-asserted-by":"publisher","first-page":"35803","DOI":"10.1074\/jbc.M705231200","volume":"282","author":"Y Li","year":"2007","unstructured":"Li Y, Wang Y, Kim E, Beemiller P, Wang CY, Swanson J, You M, Guan KL (2007) Bnip3 mediates the hypoxia-induced inhibition on mammalian target of rapamycin by interacting with Rheb. J Biol Chem 282:35803\u201335813. https:\/\/doi.org\/10.1074\/jbc.M705231200","journal-title":"J Biol Chem"},{"key":"7665_CR40","doi-asserted-by":"publisher","first-page":"5338","DOI":"10.1158\/0008-5472.CAN-04-0089","volume":"64","author":"J Okami","year":"2004","unstructured":"Okami J, Simeone DM, Logsdon CD (2004) Silencing of the hypoxia-inducible cell death protein BNIP3 in pancreatic cancer. Cancer Res 64:5338\u20135346. https:\/\/doi.org\/10.1158\/0008-5472.CAN-04-0089","journal-title":"Cancer Res"},{"key":"7665_CR41","doi-asserted-by":"publisher","first-page":"1021","DOI":"10.1158\/1078-0432.1021.11.3","volume":"11","author":"M Murai","year":"2005","unstructured":"Murai M, Toyota M, Suzuki H, Satoh A, Sasaki Y, Akino K (2005) Aberrant methylation and silencing of the BNIP3 gene in colorectal and gastric cancer. Clin Cancer Res 11:1021\u20131027","journal-title":"Clin Cancer Res"},{"key":"7665_CR42","first-page":"5940","volume":"7","author":"W Jia","year":"2014","unstructured":"Jia W, Chang B, Sun L, Zhu H, Pang L, Tao L et al (2014) REDD1 and p-AKT over-expression may predict poor prognosis in ovarian cancer. Int J Clin Exp Pathol 7:5940\u20135949","journal-title":"Int J Clin Exp Pathol"},{"key":"7665_CR43","doi-asserted-by":"publisher","first-page":"431","DOI":"10.3892\/ol.2019.11070","volume":"19","author":"Y Feng","year":"2020","unstructured":"Feng Y, Song K, Shang W, Chen L, Wang C, Pang B, Wang N (2020) REDD1 overexpression in oral squamous cell carcinoma may predict poor prognosis and correlates with high microvessel density. Oncol Lett 19:431\u2013441. https:\/\/doi.org\/10.3892\/ol.2019.11070","journal-title":"Oncol Lett"},{"key":"7665_CR44","doi-asserted-by":"publisher","first-page":"87","DOI":"10.1186\/s13000-018-0754-4","volume":"13","author":"B Chang","year":"2018","unstructured":"Chang B, Meng J, Zhu H, Du X, Sun L, Wang L, Li S, Yang G (2018) Overexpression of the recently identified oncogene REDD1 correlates with tumor progression and is an independent unfavorable prognostic factor for ovarian carcinoma. Diagn Pathol 13:87. https:\/\/doi.org\/10.1186\/s13000-018-0754-4","journal-title":"Diagn Pathol"},{"key":"7665_CR45","doi-asserted-by":"publisher","first-page":"175","DOI":"10.1186\/1471-2407-9-175","volume":"9","author":"EA Koop","year":"2009","unstructured":"Koop EA, van Laar T, van Wichen DF, de Weger RA, Ev W, van Diest PJ (2009) Expression of BNIP3 in invasive breast cancer: correlations with the hypoxic response and clinicopathological features. BMC Cancer 9:175. https:\/\/doi.org\/10.1186\/1471-2407-9-175","journal-title":"BMC Cancer"},{"key":"7665_CR46","doi-asserted-by":"publisher","first-page":"635","DOI":"10.1089\/15230860152542989","volume":"3","author":"Y Sun","year":"2001","unstructured":"Sun Y, Tan M, Duan H, Swaroop M (2001) SAG\/ROC\/Rbx\/Hrt, a zinc RING finger gene family: molecular cloning, biochemical properties, and biological functions. Antioxid Redox Signal 3:635\u2013650. https:\/\/doi.org\/10.1089\/15230860152542989","journal-title":"Antioxid Redox Signal"},{"key":"7665_CR47","doi-asserted-by":"publisher","first-page":"257","DOI":"10.1016\/s0022-2828(03)00003-8","volume":"35","author":"A Chanalaris","year":"2003","unstructured":"Chanalaris A, Sun Y, Latchman DS, Stephanou A (2003) SAG attenuates apoptotic cell death caused by simulated ischaemia\/reoxygenation in rat cardiomyocytes. J Mol Cell Cardiol 35:257\u2013264. https:\/\/doi.org\/10.1016\/s0022-2828(03)00003-8","journal-title":"J Mol Cell Cardiol"},{"key":"7665_CR48","doi-asserted-by":"publisher","first-page":"347","DOI":"10.2174\/156800911794519734","volume":"11","author":"L Jia","year":"2011","unstructured":"Jia L, Sun Y (2011) SCF E3 ubiquitin ligases as anticancer targets. Curr Cancer Drug Targets 11:347\u2013356. https:\/\/doi.org\/10.2174\/156800911794519734","journal-title":"Curr Cancer Drug Targets"},{"key":"7665_CR49","doi-asserted-by":"publisher","first-page":"1053","DOI":"10.1126\/science.288.5468.1053","volume":"288","author":"E Oda","year":"2000","unstructured":"Oda E, Ohki R, Murasawa H, Nemoto J, Shibue T, Yamashita T, Tokino T, Taniguchi T, Tanaka N (2000) Noxa, a BH3-only member of the Bcl-2 family and candidate mediator of p53-induced apoptosis. Science 288:1053\u20131058. https:\/\/doi.org\/10.1126\/science.288.5468.1053","journal-title":"Science"},{"key":"7665_CR50","doi-asserted-by":"publisher","first-page":"5945","DOI":"10.1074\/jbc.M406661200","volume":"280","author":"M Flinterman","year":"2005","unstructured":"Flinterman M, Guelen L, Ezzati-Nik S, Killick R, Melino G, Tominaga K, Mymryk JS, G\u00e4ken J, Tavassoli M (2005) E1A activates transcription of p73 and Noxa to induce apoptosis. J Biol Chem 280:5945\u20135959. https:\/\/doi.org\/10.1074\/jbc.M406661200","journal-title":"J Biol Chem"}],"container-title":["Molecular Biology Reports"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s11033-022-07665-x.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s11033-022-07665-x\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s11033-022-07665-x.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2022,9,9]],"date-time":"2022-09-09T18:38:30Z","timestamp":1662748710000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1007\/s11033-022-07665-x"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2022,6,21]]},"references-count":50,"journal-issue":{"issue":"9","published-print":{"date-parts":[[2022,9]]}},"alternative-id":["7665"],"URL":"https:\/\/doi.org\/10.1007\/s11033-022-07665-x","relation":{},"ISSN":["0301-4851","1573-4978"],"issn-type":[{"type":"print","value":"0301-4851"},{"type":"electronic","value":"1573-4978"}],"subject":[],"published":{"date-parts":[[2022,6,21]]},"assertion":[{"value":"3 February 2022","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"31 May 2022","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"21 June 2022","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"The authors have no relevant financial or non-financial interests to disclose.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Conflict of interest"}},{"value":"This study was performed in line with the principles of the Declaration of Helsinki. Approval was granted by the Ethics Committee of Marmara University School of Medicine Ethics Board; with Protocol Number: 09.2015.275; Date: 02.10.2015.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethics approval"}},{"value":"Informed consent was obtained from all individual participants included in the study.","order":4,"name":"Ethics","group":{"name":"EthicsHeading","label":"Consent to participate"}},{"value":"This manuscript does not contain any individual person\u2019s data in any form.","order":5,"name":"Ethics","group":{"name":"EthicsHeading","label":"Consent to publish"}}]}}